Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GULFPORT ENERGY CORPGPOR · Entity 2342 | Director | August 04, 2020 | August 06, 2020 |
| Yuma Energy, Inc.YUMA · Entity 144264 | Director | October 26, 2016 | November 07, 2016 |
| Yuma Energy, Inc.YUMA · Entity 181241 | Director | October 18, 2016 | October 20, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GULFPORT ENERGY CORP
Report date August 04, 2020 · Filed August 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 64,981 |
Reported balance
After 2020-08-04 transaction · row 1
1 source rowRow 1 · 2020-08-04 · Disposition to issuer · Disposed 154,867 · Balance 64,981 F1: The reported transaction involved the Reporting Person's voluntary forfeiture of 154,867 shares subject to unvested restricted stock units in connection with the issuer adopting a new director compensation program. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction involved the Reporting Person's voluntary forfeiture of 154,867 shares subject to unvested restricted stock units in connection with the issuer adopting a new director compensation program.
Yuma Energy, Inc.
Report date October 26, 2016 · Filed November 07, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,846 |
Reported balance
Holding disclosure · report date 2016-10-26 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 26,846 F1: Reflects the undersigned?s beneficial ownership of shares of common stock of the Issuer after the reincorporation of Yuma Energy, Inc., a California corporation, to Delaware and the 1-for-20 reverse stock split. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the undersigned?s beneficial ownership of shares of common stock of the Issuer after the reincorporation of Yuma Energy, Inc., a California corporation, to Delaware and the 1-for-20 reverse stock split.
Yuma Energy, Inc.
Report date October 18, 2016 · Filed October 20, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 536,926 |
Reported balance
After 2016-10-18 transaction · row 1
1 source rowRow 1 · 2016-10-18 · Grant · Acquired 367,802 · Balance 536,926 F1: The restricted stock award vested immediately upon grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock award vested immediately upon grant.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Teligent, Inc.
Report date August 19, 2020 · Filed September 16, 2020
Jointly reported with LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP, LIFE SCIENCES OPPORTUNITIES FUND II LP, SIGNET HEALTHCARE PARTNERS, LLC, GALE JAMES C, SANDERS DON A, WEIR DONALD V
Section 16 reporting ended · disclosed 2020-09-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 761,680 |
Reported balance
After 2020-08-19 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-08-19 · Sale · Disposed 74,020 · Balance 761,680 F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 136,237 |
Reported balance
After 2020-08-19 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2020-08-19 · Sale · Disposed 13,251 · Balance 136,237 F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 658,718 |
Reported balance
After 2020-08-21 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2020-08-21 · Sale · Disposed 102,962 · Balance 658,718 F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 117,805 |
Reported balance
After 2020-08-21 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2020-08-21 · Sale · Disposed 18,432 · Balance 117,805 F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 573,902 |
Reported balance
After 2020-08-25 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2020-08-25 · Sale · Disposed 84,816 · Balance 573,902 F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 102,621 |
Reported balance
After 2020-08-25 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2020-08-25 · Sale · Disposed 15,184 · Balance 102,621 F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 98,390 |
Reported balance
After 2020-08-26 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2020-08-26 · Sale · Disposed 475,512 · Balance 98,390 F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 17,515 |
Reported balance
After 2020-08-26 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2020-08-26 · Sale · Disposed 85,106 · Balance 17,515 F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 85,106 | $1.25 | $106,195.27 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 8 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,515 F2 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 26, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 475,512 | $1.24 | $591,299.17 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 7 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,390 F1 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 25, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 15,184 | $1.13 | $17,106.29 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 6 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,621 F2 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 25, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 84,816 | $1.13 | $96,147.42 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 5 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573,902 F1 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 21, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 18,432 | $1.66 | $30,539.98 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 4 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,805 F2 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 21, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 102,962 | $1.66 | $171,071.36 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 3 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658,718 F1 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 19, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 13,251 | $2.25 | $29,760.42 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 2 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,237 F2 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 19, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 74,020 | $2.26 | $167,026.13 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 1 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761,680 F1 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:00 UTC | GULFPORT ENERGY CORP GPOR · Entity 2342 | Disposition to issuerCommon Stock | 154,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045449 · doc4.xml · nonDerivative · entry 1 MORRIS BEN T · CIK 0001214494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,981 F1 · price: The reported transaction involved the Reporting Person's voluntary forfeiture of 154,867 shares subject to unvested restricted stock units in connection with the issuer adopting a new director compensation program. Read SEC document |
| July 16, 2020 Filed Jul 23, 2020 20:04 UTC | GULFPORT ENERGY CORP GPOR · Entity 2342 | GrantCommon Stock | 154,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-043466 · doc4.xml · nonDerivative · entry 1 MORRIS BEN T · CIK 0001214494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,848 F1 · shares: These securities are restricted stock units, each representing a contingent right to receive one share of common stock, par value $0.01 per share, of Gulfport Energy Corporation (the "Issuer") granted under the Issuer's equity incentive plan. The 154,867 restricted stock units reported on this form will vest in one installment on the earlier of the one-year anniversary of the grant date and the date of the 2021 Annual Meeting of Stockholders of the Issuer, in each case, if the non-employee director is in continuous service on such date. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 22:11 UTC | GULFPORT ENERGY CORP GPOR · Entity 2342 | GrantCommon Stock | 32,588 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035952 · doc4.xml · nonDerivative · entry 1 MORRIS BEN T · CIK 0001214494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,981 F1 · shares: These securities are restricted stock units, each representing a contingent right to receive one share of common stock, par value $0.01 per share, of Gulfport Energy Corporation (the "Issuer") granted under the Issuer's equity incentive plan. The 32,588 restricted stock units reported on this form will vest in one installment on the earlier of the one-year anniversary of the grant date and the date of the 2020 Annual Meeting of Stockholders of the Issuer, in each case, if the non-employee director is in continuous service on such date. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 22:37 UTC | GULFPORT ENERGY CORP GPOR · Entity 2342 | GrantCommon Stock | 11,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035336 · doc4.xml · nonDerivative · entry 1 MORRIS BEN T · CIK 0001214494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,393 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share, of Gulfport Energy Corporation (the "Issuer") and was granted under the Issuer's equity incentive plan. The 11,201 restricted stock units reported on this form will vest in one installment on the earlier of the one-year anniversary of the grant date and the date of the 2019 Annual Meeting of Stockholders of the Issuer, in each case, if the non-employee director is in continuous service on such date. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 22:01 UTC | GULFPORT ENERGY CORP GPOR · Entity 2342 | GrantCommon Stock | 9,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-038970 · doc4.xml · nonDerivative · entry 1 MORRIS BEN T · CIK 0001214494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,192 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share, of Gulfport Energy Corporation (the "Issuer") and was granted under the Issuer's equity incentive plan. The 9,608 restricted stock units reported on this form will vest in one installment on the earlier of the one-year anniversary of the grant date and the date of the 2018 Annual Meeting of Stockholders of the Issuer, in each case, if the non-employee director is in continuous service on such date. Read SEC document |
| October 18, 2016 Filed Oct 20, 2016 18:01 UTC | Yuma Energy, Inc. YUMA · Entity 181241 | GrantCommon Stock | 367,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-16-008401 · issuerdirect_section16.xml · nonDerivative · entry 1 MORRIS BEN T · CIK 0001214494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,926 F1 · price: The restricted stock award vested immediately upon grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.